SCHEDULE 13D/AFiled Mar 6, 7:00 PM ET

BridgeBio Pharma, Inc. SCHEDULE 13D/A

KKR Genetic Disorder L.P.

Summary not available

This filing does not have a generated research summary. You can still open the original filing and its exhibits.